Latest Monoclonal antibody therapy Stories
DUBLIN, May 26, 2015 /PRNewswire/ -- Research and Markets(http://www.researchandmarkets.com/research/8nqqdw/global_breast)
DUBLIN, May 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/47gwnj/antibody) has announced the addition of the "Antibody Production
MAINZ, Germany, May 19, 2015 /PRNewswire/ -- Collaboration with Genmab will focus on novel bispecific antibody products in immuno-oncology BioNTech AG, a
LONDON, May 13, 2015 /PRNewswire/ -- INTRODUCTIONThe concept of bispecific antibodies is increasingly gaining traction in the pharma industry owing to several therapeutic
Scientific Poster to be Presented at PEGS The Essential Protein Engineering Summit in Boston NEW YORK and CAMBRIDGE, Mass., May 4, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc.
Researchers at MIT have found success by combining two branches of the immune system to work fighting cancer.
- Data highlights the use and potential of PEGPH20 to enhance the anti-cancer activity of monoclonal antibodies and NK cell access in breast and ovarian cancer preclinical models - SAN DIEGO,
- Fully human mAb neutralizes multiple virulence factors of S. aureus, including alpha-hemolysin LEBANON, N.H. and VIENNA, Jan.
OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has exercised an option to receive exclusive rights to
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.